Mark Edward Bunnage

Title: Mark Edward Bunnage: Innovator in Pharmaceutical Compounds

Introduction

Mark Edward Bunnage is a notable inventor based in Concord, MA (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of novel compounds.

Latest Patents

Bunnage holds a patent for "Bicyclic-fused heteroaryl or aryl compounds." This patent discloses compounds, tautomers, and pharmaceutically acceptable salts of the compounds, characterized by the structure of Formula Ia, as defined in the specification. In one embodiment, a pharmaceutical composition can be in a liquid dosage form and can comprise a therapeutically effective amount of the compound or a pharmaceutically acceptable salt thereof as an adjuvant and a therapeutic agent. Additionally, the patent outlines a method of adjuvant treating a disorder or condition by administering the pharmaceutical composition to a patient. He has 1 patent to his name.

Career Highlights

Mark Edward Bunnage is currently associated with Pfizer Corporation, a leading global pharmaceutical company. His work at Pfizer focuses on the development of innovative therapeutic solutions that address various medical conditions.

Collaborations

Some of his notable coworkers include John David Trzupek and Katherine Lin Lee, who contribute to the collaborative efforts in research and development at Pfizer.

Conclusion

Mark Edward Bunnage exemplifies the spirit of innovation in the pharmaceutical industry through his patent and contributions at Pfizer Corporation. His work continues to impact the field positively.